Brain-Derived Neurotrophic Factor clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment

    open to eligible people ages 50-80

    This is a first-in-human clinical trial to test whether a protein administered into the brain continuously by gene therapy, Brain-Derived Neurotrophic Factor (BDNF), will slow or prevent cell loss in the brains of people affected by Alzheimer's…

    La Jolla, California and other locations

Our lead scientists for Brain-Derived Neurotrophic Factor research studies include .

Last updated: